3.80

3.26% 0.12

Cardio Diagnostics Holdings Inc (CDIO)

Overview News Price History Financials Discussions Forecast

Cardio Diagnostics Holdings Inc stock is traded at $3.80, with a volume of 29,275. It is up +3.26% in the last 24 hours and down -13.64% over the past month. Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Previous Close:

$3.68

Open:

$3.7

24h Volume:

29,275

Relative Volume:

0.52

Market Cap:

$7.88M

Revenue:

Net Income/Loss:

$-9.37M

P/E Ratio:

-4.1763

EPS:

-0.9099

Net Cash Flow:

$-7.34M

1W Performance:

+15.15%

1M Performance:

-13.64%

6M Performance:

-86.75%

1Y Performance:

-76.55%

1-Day Range:

$3.70

$3.90

1-Week Range:

$3.30

$3.90

52-Week Range:

$3.22

$53.10

Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile

Name

Cardio Diagnostics Holdings Inc

Sector

Healthcare (1160)

Industry

Biotechnology (651)

Phone

855-226-9991

Address

311 W. SUPERIOR STREET, CHICAGO

Employee

Twitter

Next Earnings Date

2024-08-12

Latest SEC Filings

CDIO's Discussions on Twitter

Compare CDIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CDIO Cardio Diagnostics Holdings Inc	3.80	7.88M	0	-9.37M	-7.34M	-0.9099
VRTX Vertex Pharmaceuticals Inc	459.62	115.95B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	547.36	56.52B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	331.91	39.44B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	543.48	35.14B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	245.49	28.51B	3.81B	-644.79M	-669.77M	-6.24

Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News

Jun 16, 2025

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Short Interest Up 53.1% in May - Defense World

Jun 16, 2025

Jun 10, 2025

Cardio Diagnostics secures Japan patent for heart disease biomarkers By Investing.com - Investing.com South Africa

Jun 10, 2025

Cardio Diagnostics secures Japanese patent for AI-driven cardiovascular disease detection technology - BioSpectrum Asia

Jun 10, 2025

Cardio Diagnostics Holdings Secures Japanese Patent For AI Cardiovascular Detection Technology - MarketScreener

Jun 10, 2025

Cardio Diagnostics (CDIO) Secures New Patent for Biomarkers in J - GuruFocus

Jun 10, 2025

Cardio Diagnostics (CDIO) Secures New Patent for Biomarkers in Japan | CDIO Stock News - GuruFocus

Jun 10, 2025

Cardio Diagnostics secures Japan patent for heart disease biomarkers - Investing.com

Jun 10, 2025

Cardio Diagnostics secures Japanese patent for set of biomarkers - TipRanks

Jun 10, 2025

Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology - Business Wire

Jun 10, 2025

Jun 09, 2025